Grant: Team Gr.: Emb. Diversity to Achieve Precision/Health Eq-Infection & Immunity-LOI
University of Manitoba
$19,955.00
Examining intersections of biographies & biologies: diversity & outcomes of people with multiple sclerosis in Canada (iBio2Div-MS)
EF 2023-24
Résumé
Over 90,000 people have multiple sclerosis (MS) in Canada. Each person with MS has a unique experience with the disease. This is likely caused by a blend of biology, lifetime experiences, and the features of the places where individuals live. Some of the differences that affect this blend include a person's sex, gender, age, ethnicity, and if they live in a city or not; these are called diversity characteristics. Past MS research has not included individuals with a broad range of diversity characteristics even though some diversity characteristics can put people with MS at a disadvantage for their health. Currently, researchers are unsure which diversity characteristics put people at the greatest health disadvantage. This in turn limits access to appropriate support and care. Our long-term goal is to improve outcomes in people with MS who have not been included in past research. We will reach our goal by using three approaches. First, we will develop ways to test how genetic factors (biology) contribute to health outcomes in people with MS. Second, we will use existing health-related data to look at how a person's biology, lifetime experiences, and environment impact their use of health care services. Third, we will find and test ways to best support people with MS who experience health disadvantages because of their experiences and environments. During our work we will actively involve diverse partners, including people with MS, health care providers, advocacy groups, and health care decision makers. Working with a comprehensive team increases the likelihood that our findings will be meaningful and helpful for improving health outcomes of people with MS, regardless of biology, lifetime experiences, and the features of the environments in which they live.
Programme
Team Gr.: Emb. Diversity to Achieve Precision/Health Eq-Infection & Immunity-LOI
Bénéficiaire
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
500713
Name
Marrie Ruth Ann
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
Team Grant: Embracing Diversity to Achieve Precision & Health Equity
Projecttitle
Examining intersections of biographies & biologies: diversity & outcomes of people with multiple sclerosis in Canada (iBio2Div-MS)
Programtype2
Operating Grants
Orgnameinp2
University of Manitoba
Cihramount2
$19,955
Cihrequipment2
$0
Programname2
Team Gr.: Emb. Diversity to Achieve Precision/Health Eq-Infection & Immunity-LOI
Keyworddelim
Multiple Sclerosis
Abstract
Over 90,000 people have multiple sclerosis (MS) in Canada. Each person with MS has a unique experience with the disease. This is likely caused by a blend of biology, lifetime experiences, and the features of the places where individuals live. Some of the differences that affect this blend include a person's sex, gender, age, ethnicity, and if they live in a city or not; these are called diversity characteristics. Past MS research has not included individuals with a broad range of diversity characteristics even though some diversity characteristics can put people with MS at a disadvantage for their health. Currently, researchers are unsure which diversity characteristics put people at the greatest health disadvantage. This in turn limits access to appropriate support and care. Our long-term goal is to improve outcomes in people with MS who have not been included in past research. We will reach our goal by using three approaches. First, we will develop ways to test how genetic factors (biology) contribute to health outcomes in people with MS. Second, we will use existing health-related data to look at how a person's biology, lifetime experiences, and environment impact their use of health care services. Third, we will find and test ways to best support people with MS who experience health disadvantages because of their experiences and environments. During our work we will actively involve diverse partners, including people with MS, health care providers, advocacy groups, and health care decision makers. Working with a comprehensive team increases the likelihood that our findings will be meaningful and helpful for improving health outcomes of people with MS, regardless of biology, lifetime experiences, and the features of the environments in which they live.
Competitiondate
202402
Approvedterm2
1 yr 0 mth
Pinamesdelim
Marrie, Ruth Ann; Finlayson, Marcia L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $19,955~ $0~